Geode Capital Management LLC Raises Stake in Estrella Immunopharma, Inc. (NASDAQ:ESLA)

Geode Capital Management LLC grew its holdings in shares of Estrella Immunopharma, Inc. (NASDAQ:ESLA) by 22.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 93,418 shares of the company’s stock after acquiring an additional 16,862 shares during the quarter. Geode Capital Management LLC’s holdings in Estrella Immunopharma were worth $106,000 at the end of the most recent quarter.

Estrella Immunopharma Price Performance

Shares of ESLA stock opened at $1.16 on Monday. The stock has a market capitalization of $41.95 million, a PE ratio of -4.46 and a beta of 0.41. Estrella Immunopharma, Inc. has a 1-year low of $0.63 and a 1-year high of $3.23. The business has a 50-day moving average of $0.95 and a 200 day moving average of $1.04.

Analysts Set New Price Targets

Separately, D. Boral Capital assumed coverage on shares of Estrella Immunopharma in a report on Tuesday, February 18th. They set a “buy” rating and a $16.00 target price on the stock.

Estrella Immunopharma Profile

Estrella Immunopharma, Inc, a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia.